Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
18 | 4 | CHEMISTRY, ANALYTICAL//TOXICOLOGY//ENVIRONMENTAL SCIENCES | 697102 |
305 | 3 | NSAIDS//TOXIC EPIDERMAL NECROLYSIS//NON STEROIDAL ANTI INFLAMMATORY DRUGS | 41294 |
923 | 2 | CYCLOOXYGENASE 2//COX 2//CYCLOOXYGENASE | 11303 |
210 | 1 | CYCLOOXYGENASE 2//COX 2//CELECOXIB | 3943 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CYCLOOXYGENASE 2 | authKW | 688751 | 14% | 16% | 555 |
2 | COX 2 | authKW | 608843 | 13% | 15% | 502 |
3 | CELECOXIB | authKW | 538673 | 8% | 21% | 316 |
4 | SULINDAC | authKW | 225661 | 2% | 34% | 82 |
5 | ASPIRIN | authKW | 135240 | 8% | 5% | 310 |
6 | NSAIDS | authKW | 127022 | 6% | 7% | 240 |
7 | CYCLOOXYGENASE | authKW | 111122 | 6% | 6% | 222 |
8 | CHEMOPREVENTION | authKW | 103452 | 6% | 6% | 227 |
9 | COX 2 INHIBITORS | authKW | 94211 | 2% | 14% | 87 |
10 | NS 398 | authKW | 93134 | 1% | 27% | 44 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 41139 | 53% | 0% | 2084 |
2 | Gastroenterology & Hepatology | 3693 | 10% | 0% | 383 |
3 | Pathology | 941 | 5% | 0% | 195 |
4 | Cell Biology | 452 | 8% | 0% | 297 |
5 | Medicine, Research & Experimental | 448 | 5% | 0% | 205 |
6 | Pharmacology & Pharmacy | 334 | 8% | 0% | 316 |
7 | Public, Environmental & Occupational Health | 101 | 4% | 0% | 141 |
8 | Urology & Nephrology | 95 | 2% | 0% | 87 |
9 | Medicine, General & Internal | 93 | 4% | 0% | 160 |
10 | Surgery | 75 | 5% | 0% | 188 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | GASTROINTESTINAL OTHER CANC GRP | 36313 | 0% | 45% | 10 |
2 | ADV MICROSCOP DIS | 23974 | 0% | 100% | 3 |
3 | INTEGRATED CANC PREVENT | 16658 | 0% | 17% | 12 |
4 | CLIN CANC PREVENT 236 | 15982 | 0% | 100% | 2 |
5 | DEFINED TUMOR MARKER EVALUAT | 15982 | 0% | 100% | 2 |
6 | EICOSANOIDS TUMOR DEV SECT | 15982 | 0% | 100% | 2 |
7 | GASTROINTESTINAL OTHER CANCERS GRP | 15982 | 0% | 100% | 2 |
8 | PROGRAMA DOCTORADO MORFOL | 15982 | 0% | 100% | 2 |
9 | HANGZHOU HOSP | 15330 | 0% | 17% | 11 |
10 | NUTR CARCINOGENESIS | 12677 | 0% | 18% | 9 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANCER PREVENTION RESEARCH | 17602 | 1% | 4% | 53 |
2 | CANCER RESEARCH | 6555 | 5% | 0% | 183 |
3 | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 5525 | 2% | 1% | 67 |
4 | PROGRESS IN EXPERIMENTAL TUMOR RESEARCH | 5431 | 0% | 6% | 12 |
5 | CLINICAL CANCER RESEARCH | 4970 | 3% | 1% | 99 |
6 | ONCOLOGY REPORTS | 4550 | 2% | 1% | 78 |
7 | CARCINOGENESIS | 3827 | 2% | 1% | 76 |
8 | ANTICANCER RESEARCH | 3479 | 2% | 0% | 94 |
9 | BRITISH JOURNAL OF CANCER | 2966 | 2% | 0% | 84 |
10 | INTERNATIONAL JOURNAL OF CANCER | 2680 | 2% | 0% | 85 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYCLOOXYGENASE 2 | 688751 | 14% | 16% | 555 | Search CYCLOOXYGENASE+2 | Search CYCLOOXYGENASE+2 |
2 | COX 2 | 608843 | 13% | 15% | 502 | Search COX+2 | Search COX+2 |
3 | CELECOXIB | 538673 | 8% | 21% | 316 | Search CELECOXIB | Search CELECOXIB |
4 | SULINDAC | 225661 | 2% | 34% | 82 | Search SULINDAC | Search SULINDAC |
5 | ASPIRIN | 135240 | 8% | 5% | 310 | Search ASPIRIN | Search ASPIRIN |
6 | NSAIDS | 127022 | 6% | 7% | 240 | Search NSAIDS | Search NSAIDS |
7 | CYCLOOXYGENASE | 111122 | 6% | 6% | 222 | Search CYCLOOXYGENASE | Search CYCLOOXYGENASE |
8 | CHEMOPREVENTION | 103452 | 6% | 6% | 227 | Search CHEMOPREVENTION | Search CHEMOPREVENTION |
9 | COX 2 INHIBITORS | 94211 | 2% | 14% | 87 | Search COX+2+INHIBITORS | Search COX+2+INHIBITORS |
10 | NS 398 | 93134 | 1% | 27% | 44 | Search NS+398 | Search NS+398 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |